Login to Your Account



EBG petitions FDA to limit term of review of combo product appeals

By Mark McCarty
Regulatory Editor

Tuesday, March 14, 2017

The regulatory law firm of Epstein Becker Green has petitioned the FDA to set a limit to the number of days the agency can take to review petitions regarding combo product designations.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription